Figure 5.

Kaplan-Meier estimated overall survival for the validation set. p-values for tests between groups were p=0.155 (Log-Rank) and p=0.018 (Wilcoxon). Grouping was done according to overexpression of ≥ 6 motility genes or/and TGF-β1. No overexpression of ≥ 6 motility genes or TGF-β1 = group 0 (red). Overexpression of ≥ 6 motility genes or TGF-β1 = group 1 (green). Overexpression of ≥ 6 motility genes and TGF-β1 = group 2 (blue).

Sergeant et al. BMC Cancer 2012 12:527   doi:10.1186/1471-2407-12-527
Download authors' original image